CHAPTER 10 226 10 References 1. Hagenbeek FA, Pool R, van Dongen J, et al. Heritability estimates for 361 blood metabolites across 40 genome-wide association studies. Nat Commun. 2020;11(1):39. 2. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tensiontype headache. Neurology. 2006;67(2):252-257. 3. Linstra KM, Ibrahimi K, Terwindt GM, Wermer MJ, MaassenVanDenBrink A. Migraine and cardiovascular disease in women. Maturitas. 2017;97:28-31. 4. Kurth T, Rist PM, Ridker PM, et al. Association of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women. JAMA. 2020;323(22):2281-2289. 5. Kurth T, Chabriat H, Bousser MG. Migraine and stroke: a complex association with clinical implications. Lancet Neurol. 2012;11(1):92-100. 6. Tanha HM, Martin NG, Whitfield JB, Nyholt DR. Association and genetic overlap between clinical chemistry tests and migraine. Cephalalgia. 2021;41(11-12):1208-1221. 7. Tanha HM, Sathyanarayanan A, Nyholt DR. Genetic overlap and causality between blood metabolites and migraine. Am J Hum Genet. 2021;108(11):2086-2098. 8. Tietjen GE, Khubchandani J. Vascular biomarkers in migraine. Cephalalgia. 2015;35(2):95-117. 9. Onderwater GLJ, Ligthart L, Bot M, et al. Large-scale plasma metabolome analysis reveals alterations in HDL metabolism in migraine. Neurology. 2019;92(16):e1899-e1911. 10. Rubino E, Vacca A, Govone F, et al. Investigating the role of adipokines in chronic migraine. Cephalalgia. 2017;37(11):1067-1073. 11. Guo Y, Daghlas I, Gormley P, et al. Phenotypic and Genotypic Associations Between Migraine and Lipoprotein Subfractions. Neurology. 2021;97(22):e2223-e2235. 12. Ferrari MD, Odink J, Bos KD, Malessy MJ, Bruyn GW. Neuroexcitatory plasma amino acids are elevated in migraine. Neurology. 1990;40(10):1582-1586. 13. Martinez F, Castillo J, Rodriguez JR, Leira R, Noya M. Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia. 1993;13(2):89-93. 14. Cananzi AP, Dandrea G, Perini F, Zamberlan F, Welch KMA. Platelet and Plasma-Levels of Glutamate and Glutamine in Migraine with and without Aura. Cephalalgia. 1995;15(2):132-135. 15. Zielman R, Wijnen JP, Webb A, et al. Cortical glutamate in migraine. Brain. 2017;140(7):1859-1871. 16. Hoffmann J, Charles A. Glutamate and Its Receptors as Therapeutic Targets for Migraine. Neurotherapeutics. 2018;15(2):361-370. 17. Folger O, Jerby L, Frezza C, et al. Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol. 2011;7:501. 18. Li L, Zhou X, Ching WK, Wang P. Predicting enzyme targets for cancer drugs by profiling human metabolic reactions in NCI-60 cell lines. BMC Bioinformatics. 2010;11:501. 19. Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997;389(6653):816-824. 20. Vriens J, Appendino G, Nilius B. Pharmacology of vanilloid transient receptor potential cation channels. Mol Pharmacol. 2009;75(6):1262-79. 21. Saloman JL, Chung MK, Ro JY. P2X₃ and TRPV1 functionally interact and mediate sensitization of trigeminal sensory neurons. Neuroscience. 2013;232:226-238. 22. Caterina MJ, Leffler A, Malmberg AB, et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 2000;288(5464):306-313. 23. Tominaga M, Caterina MJ, Malmberg AB, et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 1998;21(3):531-543. 24. Meents JE, Neeb L, Reuter U. TRPV1 in migraine pathophysiology. Trends Mol Med. 2010;16(4):153-159.
RkJQdWJsaXNoZXIy MTk4NDMw